Quantcast
Channel: BioHealth Investor » IVGN
Browsing all 4 articles
Browse latest View live

Short Sellers Lighten Up on Major Biotechs in May

We ran the short selling report that just came out on major NASDAQ biotech stocks to see what the change in short selling was.  Interestingly enough, in almost all of the major and large US biotechs...

View Article



Invitrogen Acquires Applera's Applied Biosystems (IVGN, ABI)

Invitrogen Corp. (NASDAQ: IVGN) has announced a $6.7 Billion cash and stock acquisition for Applera’s Applied Biosystems Group (NYSE: ABI).  The breakdown is 45% percent in cash and the 55% in stock....

View Article

Investors Overlooking Celera in Applied Bio-Invitrogen Merger? (CRA, ABI,...

There may be a play in this $6.7 Billion merger where Invitrogen Corp. (NASDAQ: IVGN) is acquiring Applera’s Applied Biosystems Group (NYSE: ABI).   What is interesting about this Applied Biosystems is...

View Article

BioHealth & Medical Analyst Calls (AZN, NVS, NVO, CRL, IVGN, APPY, TWTI)

BNP Paribas overseas has lowered ratings of AstraZeneca (NYSE: AZN) to Underperform from Neutral; and raised Novartis (NYSE: NVS) to Neutral from Underperform. Goldman Sachs has raised Novo Nordisk...

View Article
Browsing all 4 articles
Browse latest View live




Latest Images